ISBN:
0-226-70150-6
Language:
English
Pages:
VIII, 201 S.
DDC:
572.8072044
Keywords:
Centre d'étude du polymorphisme humain
;
Millennium Pharmaceuticals, Inc
;
Centre d'étude du polymorphisme humain
;
Millennium Pharmaceuticals, Inc
;
Millennium Pharmaceuticals Inc.
;
Centre d'Etude du Polymorphisme Humain.
;
Bio-industries - États-Unis
;
Biomedisch onderzoek
;
Cartes chromosomiques humaines - France
;
Diabetes mellitus type 2
;
Diabète non insulinodépendant - Recherche - France
;
Diabète non insulinodépendant - Recherche - États-Unis
;
Genetica
;
Genetics - Research - France - Political aspects
;
Génome humain
;
Génétique humaine - Politique gouvernementale - France
;
Medicine - Research - International cooperation - Moral and ethical aspects
;
Medicine - Research - International cooperation - Social aspects
;
Politieke aspecten
;
Samenwerking
;
Wetenschapsbeleid
;
Medizin
;
Politik
;
Biotechnology industries
;
Biotechnology
;
Biotechnology
;
Chromosome Mapping
;
Chromosome Mapping
;
Diabetes Mellitus, Type 2 genetics
;
Diabetes Mellitus, Type 2 genetics
;
Genetics
;
Genetics
;
Genome, Human
;
Genome, Human
;
Human gene mapping
;
Human genetics Government policy
;
Human genome
;
International Cooperation
;
International Cooperation
;
Non-insulin-dependent diabetes Research
;
Non-insulin-dependent diabetes Research
;
Research
;
Research
;
Genomprojekt.
;
Diabetes mellitus.
;
Gentherapie.
;
Internationale Kooperation.
;
Frankreich
;
USA
;
Frankreich.
;
USA.
;
Genomprojekt
;
Diabetes mellitus
;
Gentherapie
;
Genomprojekt
;
Internationale Kooperation
Abstract:
"In 1993, an American biotechnology company, Millennium Pharmaceuticals, and France's premier genetics lab, the Centre d'Etude du Polymorphisme Humaine (CEPH), developed plans for a collaborative effort to discover diabetes genes. The two companies had agreed that the CEPH would supply Millennium with a store of genetic material collected from a large number of French families, and Millennium would supply funding and expertise in new technologies to accelerate the identification of the genes, terms that the French government had approved. But in early 1994, just as the collaboration was to begin, the French government abruptly called a halt. The government insisted that under no circumstances could the CEPH be permitted to give the Americans that most precious of all substances - never before named in such a manner - French DNA." "French DNA is about international competition, the future of human health, ferocious financial conflict and the intersection of culture and science - the place where, finally DNA became French."--BOOK JACKET.
URL:
http://www.loc.gov/catdir/description/uchi052/99012162.html
URL:
http://www.loc.gov/catdir/bios/uchi051/99012162.html
URL:
http://www.loc.gov/catdir/toc/uchi052/99012162.html
Permalink
